The Milwaukee Academy of Medicine hosts eight educational presentations every year: once a month from January through May, and again from September through November. Distinguished national and local medical experts share their knowledge and experiences on topics of interest to a broad spectrum of medical practitioners. The didactic presentations are comprised of traditional audio-visual modalities, a discussion period involving Q&A, and the sharing of personal experiences by audience members to facilitate expert commentary and further discussion.
For more information on the Academy or to become a member, please visit: www.milwaukeeacademyofmedicine.org
Reservations are required to attend any of our programs. There is a charge for dinner and beverages.
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Physicans of all medical specialties.
At the end of this session, I will be able to:
- Recognize the differences in mechanism between THC and CBD
- Summarize the potential pharmacological benefits of manipulating the endocannabinoid system, THC and CBD as well as the potential adverse effect
- Discuss current policies regarding CBD and THC, including issues with drug screens
All persons in control of content have NO relevant financial relationships to disclose.
Milwaukee Academy of Medicine
Tuesday, November 19th, 2019
900 W. Wisconsin Avenue
COCKTAILS 6:00 P.M. DINNER 6:30 P.M. PRESENTATION 7:30 P.M.
Dinner $48 Drink options available for a separate charge.
Therapeutic Potential of the Marijuana-Derived Cannabinoids
THC and CBD
Cecilia J. Hillard, PhD
Professor of Pharmacology and Toxicology
Director of the Neuroscience Research Center
Associate Dean for Research
Medical College of Wisconsin
Cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) are both found in plants of the cannabis family. While they share some similar pharmacological effects, CBD and THC interact with the brain through very different mechanisms. I will discuss what we know about the mechanisms and therapeutic potential of the two cannabinoids. I will also present information about their measurement in bodily fluids. I am a neuropharmacologist with a primary interest in the cannabinoid-derived molecules and their targets in the brain. My research has been funded by NIH for 35 years, primarily for studies of the stress-effects of the cannabinoids and endogenous cannabinoids.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.